Clinova has developed Covaflu FFP3 disposable face masks to prevent harmful particles from entering your lungs by providing FFP3 particle filtration. Covaflu protects healthy individuals, by preventing person to person airborne contamination and filters out approximately 99% of droplets, which are 0.3 microns in size and over; the majority of sneezed droplets contaminated with influenza will be bigger in size than 0.3 microns. The folded design allows easy storage in the pocket. Covaflu complies with the World Health Organisation (WHO) and Health Protection Agency (HPA) guidelines for the minimisation of risk against influenza infection (e.g.H1N1). Clinova is currently marketing the product globally and it is currently recognised as one of the leading respirators in the global market place.
The following tables shows our clinical-stage compounds that we are developing internally or are co-developing with a partner. Please click the relevant codename for more information:
| Code Name | Brand Name | Indication | Pre Clinical | Pre Marketing (Early) | Pre Marketing (Middle) | Pre Marketing (Late) | Market Preparation / Launch |
|---|---|---|---|---|---|---|---|
| CLIN 3001 | Covaflu mask FFP2 | Pandemic Respirator | Complete |
Complete |
Complete |
Complete |
Current |
| CLIN 3002 | Covaflu mask FFP3 | Pandemic respirator | Complete |
Complete |
Complete |
Complete |
Current |
| CLIN 3003 | Quash | Hand Sanitizer | Complete |
Complete |
Complete |
Complete |
Current |
| CLIN 3004 | TBC | Painkiller | Complete |
Complete |
Complete |
Current |
Not reached |
| CLIN 3005 | Stemadermâ„¢ Cream | Topical skincare cream | Complete |
Complete |
Complete |
Complete |
Current |
| CLIN 3011 | TBC | Indigestion remedy | Complete |
Complete |
Complete |
Current |
Not reached |
| CLIN 3012 | Repelsect â„¢ | Insect patch repellent | Complete |
Complete |
Complete |
Complete |
Current |
| CLIN 3018 | ORS | Effervescent Tablets | Complete |
Complete |
Complete |
Complete |
Current |